Orca Bio

Orca Bio

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://www.orcabio.com

Last Round

Series F

1/9/2026

Est. Valuation

$2.4B

Total Funding Raised

$800M

Company Overview

Orca Bio is a biotechnology company that develops innovative cell therapy products aimed at safely replacing diseased blood and immune systems with healthy ones.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

allogeneic cell therapycell therapyT-cell immunotherapygraft-versus-host diseaseGvHDstem cell transplantblood cancer treatmenthigh-precision cell sortingliving druggraft engineeringallogeneic hematopoietic stem cell transplantalloHSCTcell therapy manufacturinghematological malignanciesacute myeloid leukemiaAMLautoimmune disease treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orca Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Orca Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series F1/9/2026
Series F12/1/2025
Series D6/17/2020
Series C5/1/2018

Key People

Founding team and executive leadership

Ivan Dimov

Co-Founder And CEO

Founding Team

Nathaniel Fernhoff

Co-Founder, Chief Executive Officer And Co-founder

Founding Team

Josh Murray

Chief Financial Officer And Head Of Strategy

Executive Team

Orca Bio Investors

Notable investors and investment history

InvestorRounds
Kaiser Permanente Group TrustSeries D
DCVC BioSeries D, VC Round
Illinois Municipal Retirement FundSeries D
Kaiser Foundation HospitalsSeries D
ND CapitalSeries D
8VCSeries C, Series D, VC Round
Mubadala Investment CompanySeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    Job posting suggests private company may be preparing for public offering.

  • Apr 7, 2026

    Hiring marketing director for US launch of Orca-T.

Orca Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orca Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orca Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range288
Year Founded2016
Last Funding1/9/2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.